| Trial ID: | L0955 |
| Source ID: | NTR2836
|
| Associated Drug: |
Omega-3 Fatty Acids
|
| Title: |
The effects of 4 weeks oral administration of omega-3 fatty acids on hepatic steatosis and insulin sensitivity in morbidly obese patients undergoing gastric bypass surgery.
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic fatty liver disease (NAFLD)
hepatic steatosis
insulin sensitivity
morbid obesity
omega-3 fatty acids
|
| Interventions: |
Eucaloric diet with high dose omega-3 fatty acids (Supportan??) vs. eucaloric diet without omega-3 fatty acids (Fresubin??) 4 weeks prior to laparoscopic Roux-Y gastic bypass surgery.
|
| Outcome Measures: |
1. To assess the effects of omega-3 fatty acids on hepatic steatosis;<br>2. To assess the effects of omega-3 fatty acids on hepatic and peripheral insulin resistance.1. Liver volume;
|
| Sponsor/Collaborators: |
--
|
| Gender: |
--
|
| Age: |
--
|
| Phases: |
Not applicable
|
| Enrollment: |
--
|
| Study Type: |
--
|
| Study Designs: |
--
|
| Start Date: |
--
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
--
|
| Locations: |
--
|
| URL: |
--
|
